• Study on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Greece Italy Spain

  • Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Portugal Spain

  • Study on the Safety and Effectiveness of Zipalertinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with Specific EGFR Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    France Germany Italy Spain

  • Study on Propranolol for Reducing Anxiety in Patients with Pancreatic Cancer Before Surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study of AZD5863 for Adults with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands

  • Study on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Ireland Italy +3

  • Study on Monitoring Untreated Multiple Myeloma in Patients Using Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone or a New Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Germany Greece Italy The Netherlands

  • Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Finland Lithuania The Netherlands Norway +1

  • Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia Denmark Finland +14

  • Study on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Bulgaria Germany Italy Romania Spain

powered by